Expiring healthcare extenders;
H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42);
H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47);
Issues related to CHANGE cyber attack;
Issues related to cybersecurity, artificial intelligence, and healthcare data privacy
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
H.R. 2474, Strengthening Medicare for Patients and Providers Act;
H.R. 3561, PATIENT Act of 2023;
H.R. 3284, Providers and Payers COMPETE Act;
Issues related to physician payment cuts;
Issues related to prior authorization in Medicare Advantage;
Healthcare policies related to year end FY24 appropriations spending bills;
Issues related to CHANGE cyber attack
Duration: March 1, 2016
to
present
General Issues: Health Issues , Medicare/Medicaid , Small Business , Budget/Appropriations , Veterans , Taxation/Internal Revenue Code
Spending: about $1,940,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), House of Representatives, White House Office
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Tracy Spicer Deputy Chief of Staff, Political Director, Legislative Assistant, Special Assistant, Staff Assistant - Sen. Edward M. Kennedy
Amy Tejral Legislative Director - Sen. Ben Nelson
Elizabeth Barnett Legislative Assistant, Speechwriter, Legislative Correspondent - Sen. Blanche Lincoln; Staff Assistant - Senate Energy and Natural Resources Committee
Yvette Fontenot n/a
Jordan LaCrosse n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 22.
Original Filing: 301574194.xml
Lobbying Issues
Expiring healthcare extenders;
H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42);
H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47);
Issues related to CHANGE cyber attack;
Issues related to cybersecurity, artificial intelligence, and healthcare data privacy
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
H.R. 2474, Strengthening Medicare for Patients and Providers Act;
H.R. 3561, PATIENT Act of 2023;
H.R. 3284, Providers and Payers COMPETE Act;
Issues related to physician payment cuts;
Issues related to prior authorization in Medicare Advantage;
Healthcare policies related to year end FY24 appropriations spending bills;
Issues related to CHANGE cyber attack
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 22.
Original Filing: 301539307.xml
Lobbying Issues
Issues related to cybersecurity and artificial intelligence in the healthcare sector;
Expiring healthcare extenders
Lobbying Issues
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
H.R. 2474, Strengthening Medicare for Patients and Providers Act;
H.R. 3561, PATIENT Act of 2023;
H.R. 3284, Providers and Payers COMPETE Act;
H.R. 4822, Health Care Price Transparency Act of 2023;
Issues related to physician payment cuts;
Issues related to prior authorization in Medicare Advantage;
Healthcare policies related to year end FY24 appropriations spending bills
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 20, 2023.
Original Filing: 301510911.xml
Lobbying Issues
Issues related to cybersecurity and artificial intelligence in the healthcare sector
Lobbying Issues
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
H.R. 2474, Strengthening Medicare for Patients and Providers Act;
H.R. 3561, PATIENT Act of 2023;
H.R. 3284, Providers and Payers COMPETE Act;
H.R. 4822, Health Care Price Transparency Act of 2023;
Issues related to physician payment cuts;
Issues related to prior authorization in Medicare Advantage
2nd Quarter, 2023
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 19, 2023.
Original Filing: 301483924.xml
Lobbying Issues
Issues related to cybersecurity in the healthcare sector
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
H.R. 2474, Strengthening Medicare for Patients and Providers Act;
H.R. 3561, PATIENT Act of 2023;
H.R. 3284, Providers and Payers COMPETE Act;
Issues related to physician payment cuts;
Issues related to prior authorization in Medicare Advantage
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 20, 2023.
Original Filing: 301464108.xml
Lobbying Issues
Issues related to cybersecurity in the healthcare sector;
H.J.Res.7, terminating the national emergency related to the COVID-19 pandemic;
Implementation of the No Surprises Act (P.L. 116-260)
Lobbying Issues
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
Issues related to physician payment cuts;
Issues related to prior authorization in Medicare Advantage;
Contract Year 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F);
CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 20, 2023.
Original Filing: 301439544.xml
Lobbying Issues
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
H.R. 8800, The Supporting Medicare Providers Act of 2022;
Issues related to physician payment cuts, including APM bonuses;
Telehealth issues related to COVID-19;
Health disparities;
H.R. 2617, Consolidated Appropriations Act, 2023 - increasing Medicare Physician Fee Schedule payments and extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31, 2024;
Issues related to the implementation of the No Surprises Act;
S. 3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Senate Finance Committe bipartisan Discussion Draft: Mental Health Workforce
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Committee Print 117-1 - Improvements to Medicare Inpatient and Outpatient Mental Health Services (H.R. 8879, Inpatient Psychiatric Facility Improvement Act; H.R. 8878, To amend title XVIII of the Social Security Act to ensure adequate coverage of outpatient mental health services under the Medicare program);
Committee Print 117-2 - Improvements to the Medicare Program Related to Physician Services and Education (H.R. 432, Mental Health Access Improvement Act of 2021; H.R. 8910, Behavioral Health Integration Awareness Act of 2022; H.R. 8884, To direct the Secretary of Health and Human Services to provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs under the Medicare program; H.R. 8890, Physician Wellness Program Act of 2022; H.R. 8908, Fighting Stimulant and other Substance Use Disorders Act);
Committee Print 117-3 - Requiring Coverage of Forensic Medical Exams with No Cost Sharing (H.R. 8891, No Surprises for Survivors Act of 2022);
Committee Print 117-4 - Improved Information in Provider Directories, Plan Definitions and Crisis Services for Private Insurance Plans (H.R. 8885, Better Health Care Directories Act; H.R. 8886, Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act; H.R. 8892, To direct the Secretary of Health and Human Services to conduct a public outreach campaign to inform individuals covered under a group health plan or group or individual health insurance coverage of Federal requirements relating to mental health and substance use disorder crisis services, and for other purposes);
Committee Print 117-5 - Improved Information for Network Coverage and Plan Documents in Private Insurance Plans (H.R. 8881, To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types, and for other purposes; H.R. 8889, Readable Insurance Coverage Explanations Act (RICE Act));
Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022));
Issues related to the Public Health Emergency;
S. 368/H.R. 1332, Telehealth Modernization Act;
H.R. 7007, COVID Supplemental Appropriations Act, 2022;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act;
H.R.6087, Improving Access to Workers Compensation for Injured Federal Workers Act;
Issues related to medical student federal loan forgiveness;
Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth Expansion Act;
Issues related to the Administration's Test to Treat initiative;
S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021;
H.R. 8800, The Supporting Medicare Providers Act of 2022;
Issues related to physician payment cuts;
H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2022;
Advancing Interoperability and Improving Prior Authorization Processes Proposed Rule CMS-0057-P;
Issues related to RAD-V;
CY 2023 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule with Comment Period CMS 1772-FC
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413113.xml
Lobbying Issues
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule;
H.R. 8800, The Supporting Medicare Providers Act of 2022;
Issues related to physician payment cuts, including APM bonuses;
Telehealth issues related to COVID-19;
Health disparities;
Issues related to H.R. 5376, Inflation Reduction Act of 2022 (now PL 117-169) and implementation;
Issues related to the Continuing Resolution, H.R.6833;
Issues related to the implementation of the No Surprises Act;
S. 3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Senate Finance Committe bipartisan Discussion Draft: Mental Health Workforce
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Committee Print 117-1 - Improvements to Medicare Inpatient and Outpatient Mental Health Services (H.R. 8879, Inpatient Psychiatric Facility Improvement Act; H.R. 8878, To amend title XVIII of the Social Security Act to ensure adequate coverage of outpatient mental health services under the Medicare program);
Committee Print 117-2 - Improvements to the Medicare Program Related to Physician Services and Education (H.R. 432, Mental Health Access Improvement Act of 2021; H.R. 8910, Behavioral Health Integration Awareness Act of 2022; H.R. 8884, To direct the Secretary of Health and Human Services to provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs under the Medicare program; H.R. 8890, Physician Wellness Program Act of 2022; H.R. 8908, Fighting Stimulant and other Substance Use Disorders Act);
Committee Print 117-3 - Requiring Coverage of Forensic Medical Exams with No Cost Sharing (H.R. 8891, No Surprises for Survivors Act of 2022);
Committee Print 117-4 - Improved Information in Provider Directories, Plan Definitions and Crisis Services for Private Insurance Plans (H.R. 8885, Better Health Care Directories Act; H.R. 8886, Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act; H.R. 8892, To direct the Secretary of Health and Human Services to conduct a public outreach campaign to inform individuals covered under a group health plan or group or individual health insurance coverage of Federal requirements relating to mental health and substance use disorder crisis services, and for other purposes);
Committee Print 117-5 - Improved Information for Network Coverage and Plan Documents in Private Insurance Plans (H.R. 8881, To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types, and for other purposes; H.R. 8889, Readable Insurance Coverage Explanations Act (RICE Act));
Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022));
Issues related to the Public Health Emergency;
S. 368/H.R. 1332, Telehealth Modernization Act;
H.R. 7007, COVID Supplemental Appropriations Act, 2022;
Issues related to the FY 2023 President's Budget;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act;
H.R.6087, Improving Access to Workers Compensation for Injured Federal Workers Act;
Issues related to medical student federal loan forgiveness
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth Expansion Act;
Issues related to the Administration's Test to Treat initiative;
S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021;
H.R. 8800, The Supporting Medicare Providers Act of 2022;
Issues related to physician payment cuts;
H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act of 2022
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 20, 2022.
Original Filing: 301391860.xml
Lobbying Issues
Telehealth issues related to COVID-19;
Health disparities;
Monitor healthcare policies in reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based service, prescription drug reforms;
H.R. 5376, Build Back Better;
Issues related to the implementation of the No Surprises Act;
S.3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth;
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Issues related to reauthorization of FDA user fee bills (H.R.7667, Food and Drug Amendments of 2022; S.4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022));
Issues related to the Public Health Emergency;
S. 368/H.R. 1332, Telehealth Modernization Act;
H.R. 7007, COVID Supplemental Appropriations Act, 2022;
Issues related to the FY 2023 Presidents Budget;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act;
H.R.6087, Improving Access to Workers Compensation for Injured Federal Workers Act;
Issues related to medical student federal loan forgiveness
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth Expansion Act;
Issues related to the Administration's Test to Treat initiative;
S. 3018/HR. 3173, Improving Seniors Timely Access to Care Act of 2021
1st Quarter, 2022
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 20, 2022.
Original Filing: 301370827.xml
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Telehealth issues related to COVID-19;
Health disparities;
Monitor healthcare policies in reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based service, prescription drug reforms;
H.R. 5376, Build Back Better;
Issues related to the implementation of the No Surprises Act;
Consolidated Appropriations Act, 2022 (PL 117-103);
S.3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Issues related to reauthorization of the FDA user fee bills;
Issues related to the Public Health Emergency;
S. 368/H.R. 1332, Telehealth Modernization Act
H.R. 7007, COVID Supplemental Appropriations Act, 2022;
Issues related to the FY 2023 Presidents Budget
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth Expansion Act;
Medicare Accelerated and Advance Payments Improvement Act;
Extension of the Medicare Sequester Relief;
S. 748, Medicare Sequester Relief Act;
H.R. 1999, To delay and offset the sequester under the Statutory Pay-As-You-Go Act of 2010 as a result of the enactment of the American Rescue Plan Act of 2021, and for other purposes;
Protecting Medicare and American Families from Sequester Cuts Act (PL-117-71) - specifically: 6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo;
Issues related to the Administration's Test to Treat initiative
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 19, 2022.
Original Filing: 301329746.xml
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Telehealth issues related to COVID-19;
Health disparities;
Continue monitoring Consolidated Appropriations Act, 2021 (PL 116-260);
Monitor healthcare policies in reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based service, prescription drug reforms;
H.R. 5376, Build Back Better;
PL 117-58 - Infrastructure Investment and Jobs Act (BIF) - issues related to rebate rule delay, repurposed Provider Relief Funds, Medicare savings from single source vial size drug policy and extension of mandatory sequester);
Requirements Related to Surprise Billing; Part I (A Rule by the Personnel Management Office, the Internal Revenue Service, the Employee Benefits Security Administration, and the Health and Human Services Department on 07/13/2021);
Requirements Related to Surprise Billing; Part II Interim Final Rule with Comment Period
Sep 30, 2021;
HHS Released Guidance on Provisions Established in Surprise Billing, Part II; Interim Final Rule with Comment Period (CMS 9908-IFC) (12/21)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth Expansion Act;
Medicare Accelerated and Advance Payments Improvement Act;
Extension of the Medicare Sequester Relief;
S. 748, Medicare Sequester Relief Act;
Issues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule;
H.R. 1999, To delay and offset the sequester under the Statutory Pay-As-You-Go Act of 2010 as a result of the enactment of the American Rescue Plan Act of 2021, and for other purposes;
CMS Final Rule - Medicare Program: CY 2022 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; etc. (11/2);
CY 2022 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule (CMS-1753FC);
PL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically: 6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 20, 2021.
Original Filing: 301313389.xml
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Telehealth issues related to COVID-19;
Health disparities;
Continue monitoring Consolidated Appropriations Act, 2021 (PL 116-260);
Monitor healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based service, prescription drug reforms;
S. 2210, Better Care Better Jobs Act
H.R. 5376, Build Back Better
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth Expansion Act;
Medicare Accelerated and Advance Payments Improvement Act;
Extension of the Medicare Sequester Relief;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Issues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule;
H.R. 1999, To delay and offset the sequester under the Statutory Pay-As-You-Go Act of 2010 as a result of the enactment of the American Rescue Plan Act of 2021, and for other purposes.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 20, 2021.
Original Filing: 301289475.xml
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Telehealth issues related to COVID-19;
Health disparities;
Continue monitoring Consolidated Appropriations Act, 2021 (PL 116-260);
Healthcare for migrant children at the border;
Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services;
Senate HELP and Energy & Commerce Public Option RFI;
S. 2210, Better Care Better Jobs Act
Lobbying Issues
Telehealth Expansion Act;
Medicare Accelerated and Advance Payments Improvement Act;
Issues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule;
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 20, 2021.
Original Filing: 301261557.xml
Lobbying Issues
H.R. 1319, American Rescue Plan Act of 2021 (PL 117-2);
Telehealth issues related to COVID-19;
Health disparities;
Continue monitoring Consolidated Appropriations Act, 2021 (PL 116-260)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Telehealth Expansion Act;
Medicare Accelerated and Advance Payments Improvement Act;
Issues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule;
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 21, 2021.
Original Filing: 301243680.xml
Lobbying Issues
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019;
S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019;
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
Telehealth issues related to COVID-19;
H.R, 6800, The Heroes Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
Health disparities;
H.R. 925, The Heroes Act;
H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act (Public Law 116-159);
H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)
Agencies Lobbied
U.S. Senate
Lobbying Issues
S 4230, Telehealth Expansion Act of 2020;
S.3750/HR 6837, Medicare Accelerated and Advance Payments Improvement Act of 2020;
Issues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule;
Extension of the Medicare Sequester;
H.R. 133,Consolidated Appropriations Act, 2021 (Public Law 116-260)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 20, 2020.
Original Filing: 301222664.xml
Lobbying Issues
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019;
S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019;
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
Telehealth issues related to COVID-19;
H.R, 6800, The Heroes Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
Health disparities;
H.R. 925, The Heroes Act;
H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; Public Law 116-159
Agencies Lobbied
U.S. Senate
Lobbying Issues
S 4230, Telehealth Expansion Act of 2020;
S.3750/HR 6837, Medicare Accelerated and Advance Payments Improvement Act of 2020;
Issues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule
Agencies Lobbied
U.S. Senate
Lobbying Issues
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to SBA loans for physicians, providers and small businesses
2nd Quarter, 2020
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 20, 2020.
Original Filing: 301201631.xml
Lobbying Issues
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019;
S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019;
S. 948, Conrad State 30 and Physician Access Reauthorization Act;
H.R. 3107, Improving Seniors Timely Access to Care Act of 2019;
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
Telehealth issues related to COVID-19;
H.R, 6800, HEROES Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
Health disparities
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and legislative improvements
Lobbying Issues
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to SBA loans for physicians, providers and small businesses
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
Avenue Solutions amended a lobbying report for representation of American Medical Association in Q12020 on July 20, 2020.
Original Filing: 301201625.xml
Lobbying Issues
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019;
S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019;
S. 948, Conrad State 30 and Physician Access Reauthorization Act;
H.R. 3107, Improving Seniors Timely Access to Care Act of 2019;
H.R. 6074 (Public Law 116-123), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
H.R. 6201 (Public Law 116-127), Families First Coronavirus Response Act;
H.R. 748 (Public Law 116-136), CARES Act - proposals related to physician and provider relief;
S. 3559/H.R. 6365, A bill to provide emergency financial assistance to rural health care facilities and providers impacted by the COVID-19 emergency
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and legislative improvements
Lobbying Issues
H.R. 748 (Public Law 116-136), CARES Act - proposals related to SBA loans for physicians, providers and small businesses
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 17, 2020.
Original Filing: 301170014.xml
Lobbying Issues
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019;
S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019;
S. 948, Conrad State 30 and Physician Access Reauthorization Act;
H.R. 3107, Improving Seniors Timely Access to Care Act of 2019;
H.R. 6074 (Public Law 116-123), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
H.R. 6201 (Public Law 116-127), Families First Coronavirus Response Act;
H.R. 748 (Public Law 116-136), CARES Act - proposals related to physician and provider relief;
S. 3559/H.R. 6365, A bill to provide emergency financial assistance to rural health care facilities and providers impacted by the COVID-19 emergency
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and legislative improvements
Lobbying Issues
H.R. 748 (Public Law 116-136), CARES Act - proposals related to SBA loans for physicians, providers and small businesses
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 18, 2020.
Original Filing: 301120898.xml
Lobbying Issues
Issues related to opioids policies;
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Confidentiality related to substance use disorder patient medical records;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019;
H.R. 1865, Consolidated Domestic and International Assistance Bill
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and legislative improvements
3rd Quarter, 2019
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 17, 2019.
Original Filing: 301068889.xml
Lobbying Issues
Issues related to opioids policies;
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Confidentiality related to substance use disorder patient medical records;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019
Lobbying Issues
MACRA implementation and legislative improvements
2nd Quarter, 2019
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 19, 2019.
Original Filing: 301052601.xml
Lobbying Issues
Issues related to opioids policies;
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Confidentiality related to substance use disorder patient medical records;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019;
S. 1895, Lower Health Care Costs Act of 2019;
H.R. 3630, No Surprises Act;
H.R. 3502, Protecting People From Surprise Medical Bills Act;
H.R. 861, End Surprise Billing Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and legislative improvements
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to Title X, funding for family planning services
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 19, 2019.
Original Filing: 301031077.xml
Lobbying Issues
Issues related to opioids policies;
Issues related to the Trump Administration's support for Texas lawsuit that would rule ACA unconstitutional;
Confidentiality related to substance use disorder patient medical records;
Monitor issues related to healthcare cost, surprise billing issues and transparency;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
Issues related to strengthening and protecting the Afortable Care Act including, H.R. 1385, SAVE Act; H.R. 1386, ENROLL Act of 2019; H.R. 987, MORE Health Education Act; H.R. 1010, To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; H.R. 986, Protecting Americans with Preexisting Conditions Act of 2019; H.R. 1425, State Health Care Premium Reduction Act;
Issues related to gun control
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and issues related to evaluation and management (E&M) codes
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to Title X, funding for family planning services
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 21, 2019.
Original Filing: 301012047.xml
Lobbying Issues
Issues related to opioids policies;
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act (SUPPORT for Patients and Communities Act);
S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);
S. 2680, Opioid Crisis Response Act of 2018;
Monitor drug pricing initiatives;
Confidentiality related to substance use disorder patient medical records;
Surprise billing issues, Senate price transparency working group draft legislation;
S. 1850, Protecting Jessica Grubb's Legacy Act - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and issues related to evaluation and management (E&M) codes;
GAO study on geographic practice cost indicators (GPCI)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 19, 2018.
Original Filing: 300990522.xml
Lobbying Issues
Issues related to opioids policies;
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act (SUPPORT for Patients and Communities Act);
S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);
S. 2680, Opioid Crisis Response Act of 2018;
Monitor drug pricing initiatives;
Confidentiality related to substance use disorder patient medical records;
Surprise billing issues;
S. 1850, Protecting Jessica Grubb's Legacy Act - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and issues related to evaluation and management (E&M) codes
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2018
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 19, 2018.
Original Filing: 300970484.xml
Lobbying Issues
Issues related to opioids policies;
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act (SUPPORT for Patients and Communities Act);
S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);
S. 2680, Opioid Crisis Response Act of 2018;
Monitor drug pricing initiatives
Agencies Lobbied
U.S. Senate
Lobbying Issues
MACRA implementation and issues related to misvalued codes
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 19, 2018.
Original Filing: 300951166.xml
Lobbying Issues
MACRA implementation and issues related to misvalued codes;
Insurance market stabilization policies;
Cost-sharing reduction subsidies (Alexander-Murray proposal);
Issues related to opioids policies;
Issues related to healthcare discussions in budget deal and healthcare extender policies;
H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018;
H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 22, 2018.
Original Filing: 300934948.xml
Lobbying Issues
MACRA implementation and technical corrections;
Insurance market stabilization policies;
Cost-sharing reduction subsidies (Alexander-Murray proposal);
S. 892, Opioid Addiction Prevention Act;
S. 1835 Lower Premiums Through Reinsurance Act of 2017;
Issues related to year-end healthcare discussions/offsets for budget deal and healthcare extender policies
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.1797, Veteran's Choice Accountability Act - telemedicine proposal
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1, Tax Cuts and Jobs Act (P.L. 115-97)- issues related to the individual mandate repeal, deduction on student loans and medical expense deductions
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905430.xml
Lobbying Issues
MACRA implementation;
H.R. 1628, American Health Care Act of 2017;
Insurance market stabilization policies;
Cost-sharing reduction subsidies;
Medicaid reform;
S. 892, Opioid Addiction Prevention Act;
Better Care Reconciliation Act;
Graham-Cassidy healthcare reconciliation bill
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 19, 2017.
Original Filing: 300888565.xml
Lobbying Issues
MACRA implementation;
H.R. 1628, American Health Care Act of 2017;
Insurance market stabilization policies;
Cost sharing reduction subsidies;
Medicaid reform;
S. 892, Opioid Addiction Prevention Act;
Better Care Reconciliation Act Discussion Draft
1st Quarter, 2017
In Q1, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on April 20, 2017.
Original Filing: 300874684.xml
Lobbying Issues
MACRA implementation;
H.R. 1628, American Health Care Act of 2017 (AHCA);
Insurance market stabilization policies
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Jan. 23, 2017.
Original Filing: 300856413.xml
Lobbying Issues
Mental health initiatives (H.R. 2646, Helping Families in Mental Health Crisis Act of 2016; S. 1945, Mental Health Reform Act of 2015);
Opioid abuse (H.R. 953, Comprehensive Addiction and Recovery Act of 2015; S. 524, Comprehensive Addiction and Recovery Act of 2016);
Prescription drug diversion and abuse initiatives;
Health information technology - meaningful use;
Senate HELP Committee's Working Group on Innovations;
Zika funding;
MACRA implementation;
H.R. 6, 21st Century Cures Act;
H.R. 5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on Oct. 20, 2016.
Original Filing: 300837174.xml
Lobbying Issues
Mental health initiatives (H.R. 2646, Helping Families in Mental Health Crisis Act of 2016; S. 1945, Mental Health Reform Act of 2015);
Opioid abuse (H.R. 953, Comprehensive Addiction and Recovery Act of 2015; S. 524, Comprehensive Addiction and Recovery Act of 2016);
Prescription drug diversion and abuse initiatives;
Health information technology - meaningful use;
Senate HELP Committee's Working Group on Innovations;
Zika funding;
MACRA implementation;
H.R. 6, 21st Century Cures Act;
H.R. 5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Avenue Solutions lobbied for American Medical Association , earning $60,000. The report was filed on July 19, 2016.
Original Filing: 300814350.xml
Lobbying Issues
Mental health initiatives;
Opioid abuse;
Prescription drug diversion and abuse initiatives;
Health information technology - meaningful use;
Senate HELP Committee's Working Group on Innovations;
Zika funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
CMS/CMMI Medicare Part B Drug Payment Model;
Meaningful use;
MACRA rule;
Hospital bill- site neutral payment policy;
Stark modernization efforts
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
Avenue Solutions amended a lobbying report for representation of American Medical Association in Q12016 on April 21, 2016.
Original Filing: 300804010.xml
Lobbying Issues
Mental health initiatives;
Opioid abuse;
Prescription drug diversion and abuse initiatives;
Health information technology - meaningful use;
Senate HELP Committee's Working Group on Innovations
Agencies Lobbied
U.S. Senate
Lobbying Issues
CMS/CMMI Medicare Part B Drug Payment Model;
Meaningful use
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Avenue Solutions lobbied for American Medical Association , earning $20,000. The report was filed on April 20, 2016.
Original Filing: 300799912.xml
Lobbying Issues
Mental health initiatives;
Opioid abuse;
Prescription drug diversion and abuse initiatives;
Health information technology - meaningful use;
Senate HELP Committee's Working Group on Innovations
Agencies Lobbied
U.S. Senate
Lobbying Issues
CMS/CMMI Medicare Part B Drug Payment Model;
Meaningful use
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
Avenue Solutions filed a lobbying registration on March 16, 2016 to represent American Medical Association, effective March 1, 2016.
Original Filing: 300787477.xml
Issue(s) they said they’d lobby about: Health care policy, MACRA implementation, ACA implementation, opioid abuse, Medicare, health information technology .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...